Precision growth meets capex inflection — Q1 at a scale inflection point
Harsha Engineers reports Q1 FY27 on August 11 with momentum from a strong FY26 close. The real story: ₹110-crore subsidiary capex signals confidence in the China+1 reshoring cycle. Watch whether Q1 holds FY26's run-rate or slides seasonally, and how margin expansion tracks the new capacity ramp.
What to Expect: The Trajectory
Harsha Engineers closed FY26 with momentum. Q4 standalone revenue hit ₹355.85 crore — the strongest quarter in the dataset — and net profit reached ₹53.17 crore with operating margins of 19.53%. The full-year trajectory was clear: Q1 FY26 at ₹271 Cr ramped to Q4 at ₹355 Cr, a 31% intra-year acceleration. But Q1 is historically seasonal for the precision bearing cage business (customer destocking post-FY close, June quarter typically lighter). The Street will watch whether Harsha holds momentum or slides to the ₹280–300 Cr range — a "normal" Q1.
~₹280–300 Cr
Seasonal dip from Q4's ₹355.85 Cr; momentum dependent on export orders
~14–16%
Consolidated basis; standalone typically 18–19%. Margin floor set by subsidiary ramp and forex headwinds.
~₹3.8–4.2
Q4 FY26 was ₹5.19; Q1 usually lighter due to seasonality
Capex deployment
Harsha Advantek's ₹110 Cr Phase 2 investment — pace and margin impact
On Track? The Momentum & the Capex Story
Yes, on track — but with a caveat. The company signaled aggressive growth confidence in May 2026 by announcing ₹110 crores of capex through Harsha Advantek for capacity expansion (Phase 2). This is not a guided number from management guidance; it's a board decision flagged via announcement. The implication: Harsha sees multi-year demand tailwinds, likely from the China+1 reshoring cycle and global bearing giants (Schaeffler, SKF, TATA Bearings) diversifying supply. As the world's leading Indian precision bearing cage manufacturer with ~50% domestic market share and 51% export revenue, Harsha is well-positioned to capture share in this reset.
The capex inflection matters: it signals conviction but also introduces Q1–Q2 FY27 headwinds. New facility construction (Bhayla, Ahmedabad) will weigh on profitability in the near term (depreciation, integration costs). Watch for management commentary on deployment pace and when the new lines reach commercial production. A 14% consolidated OPM in Q1 would be a floor — the company has held 14–15% consolidated margins even as it ramps.
Since Last Quarter: The Filings Scan
May 7, 2026
FY26 Audited Results & ₹1.5 Final Dividend Recommended (15% payout)
Routine; strong capital return
May 28, 2026
Harsha Advantek Phase 2: ₹110 Cr Capex for Capacity Expansion
KEY — signals 2–3 yr growth cycle
June 24, 2026
Trading Window Closed for Q1 FY27 Results
Routine compliance
July 23, 2026
16th AGM Held; Final Dividend Approved
Routine; ₹1.5/share (15%) approved by shareholders
August 1, 2026
Rajesh Nirmal, General Manager (Logistics & Commercial), Retires
28-year tenure; succession in place (no vacancy announcement)
August 3, 2026
New Statutory Auditor: Mukesh M. Shah & Co (5-year term)
Routine; auditor rotation post-IPO
What the Street is Watching (Consensus & Debate)
Analyst coverage of Harsha Engineers is limited — the stock is a mid-cap precision play, not a household name, and coverage thins outside of Tier-1 brokers. The public debate, where it exists, hinges on two axes:
On valuation: at ₹432.6 with a market cap of ~₹4,270 crore and recent annualized EPS run-rate of ~₹18–20 (on full-year basis), the P/E is ~21–24x. That's a modest premium to the Nifty 50 (but fair for a compounder in precision engineering). No recent target-price moves have been widely publicized; the stock trades on momentum and capex-cycle sentiment.
The Setup: Q1 FY27 Read
Harsha Engineers enters Q1 FY27 results at a scale inflection point. The ₹110-crore capex announcement and the strength of Q4 FY26 (₹355.85 Cr standalone revenue) set high expectations. But Q1 is seasonally light, and the real test is whether management can guide the Street through the capex ramp without a material margin cut. Expect a dip from Q4's ₹355 Cr — into the ₹280–300 Cr range — but watch for reassurance on capex deployment pace and margin recovery trajectory.
Three things to watch on August 11: (1) Q1 Revenue & Margin — is the ₹280–300 Cr and 14–16% OPM range on point, or worse? (2) Capex Update — how much of the ₹110 Cr has been deployed, and when does the new Bhayla facility go live? (3) FY27 Guidance — does Harsha reaffirm its multi-year growth trajectory, or signal caution on demand/FX? Any commentary on pricing power amid the new capacity ramp will matter for the margin debate.
The stock, at ₹432.6 above key moving averages but 7.7% below ATH, is positioned for a data-driven move. A beat on revenue or margin would trigger momentum; a miss could test support at SMA50 (₹415.54).
Strong topline growth masking margin pressure from commodity headwinds
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit prior double-digit revenue guidance; margin guidance being walked down cautiously (24% → 20-22%); subsidiaries still loss-making
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong revenue delivery (+25% YoY) and near-term growth drivers (Bushing 35%, Stamping 31%, CapEx ramp) offset by PAT decline despite topline growth and aggressive FY27 targets. Margin recovery hinges on RM pass-through timing and Advantek needing 3.25x growth in 9 months.
₹457.4 Cr
Revenue · +25.2% YoY₹37.4 Cr
Reported PAT · −1.5% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Satisfactory Q1 performance in line with management plan
OVERSTATEDRevenue +25% YoY exceeded guidance; PAT flat/down -1.5% despite topline growth
Pass-through of 8% RM increase will normalize margins in Q2
PartialOPM fell 150 bps YoY; margin recovery timing unverified, dependent on customer acceptance
Strong 21% growth in India Engineering with 6% QoQ growth
METConfirmed; India segment delivered 21% YoY and 6% QoQ despite macro headwinds
Bushing targeting 30% growth FY27 with strong visibility
METQ1 delivered 35% YoY; but order book and pipeline assurances lack specifics
Advantek ₹140 Cr+ revenue target for FY27
MISSQ1 ₹30 Cr, FY26 ₹43 Cr; requires 3.25x growth in 3 quarters, highly aggressive
Earnings quality
What changed since the last call
India guidance upgraded to high-teens
UpgradePrior mid-teens (14-15%), now high-teens (16%+); Q1 delivered 21% supports upgrade but Q4 FY26 was typically strongest
Japan customer growth downgraded to 10%
DowngradeQ1 showed 25% growth (₹21 Cr) but full-year guidance capped at 10% (₹80 Cr); management cited slow project pipeline
Margin guidance narrowed to 20-22% band
DowngradeStandalone Q1 was 24%; new guidance reflects RM cost impact and capex ramp costs; prior was 'maintain current profile'
Romania losses timeline pushed
NeutralCombined China + Romania target of ₹2-3 Cr loss from ₹10 Cr in FY26; breakeven now 'maybe next year' vs prior expectation
The Q&A
Q&A was pointed: analysts pressed on Romania's path to profitability (management hedged with 'gradually reduce losses'), large-Cages Q1 weakness (blamed capacity ramp), and Japan guidance downgrade (acknowledged 'laggard in terms of growth'). Management held firm on targets but offered minimal specificity on subsidiary recovery mechanics.
Revenue growth drivers — Varun Jain, Dolat Capital
AnsweredBroad-based: industrial demand strengthening globally + European recovery. Growth across all segments.
FY27 growth guidance — Varun Jain, Dolat Capital
AnsweredNo, 20% is very tough stretch. Mid-to-high-teens India, low-teens consolidated expected.
Margin compression — Varun Jain, Dolat Capital
AnsweredAcross the board: brass, copper, zinc, steel, polymer. Global conditions impacted all materials.
Foreign subsidiary margins — Varun Jain, Dolat Capital
PartialRM costs continuing to rise, negating revenue upside. Romania FX loss ₹2 Cr also impacted.
Romania recovery plan — Amit Anwani, PL Capital
PartialWorking on it but limited numbers so far. Pipeline improving toward cages; combined loss ₹2-3 Cr by FY27 end target.
Bushing growth sustainability — Amit Anwani, PL Capital
AnsweredConversion effect + wallet share. Expect conversion to continue 1-2 years; addition of new products also supporting.
Large-size Cages weakness — Amit Anwani, PL Capital
AnsweredQ1 was aberration due to capacity ramp-up at new facility. Strong order book and pipeline support 50% confidence.
CapEx progress update — Vaibhav Shah, Equirus Securities
AnsweredChina Phase-2 on track for Q3 FY28 commissioning. Bhayla Phase-2 construction rolling; expect ₹50-80 Cr this year.
Core Cages growth (excl. new products) — Manish Goyal, ThinkWise
AnsweredYes, driven by Indian economy growth + outsourcing + customer export plants. Should match bearing industry growth 10%+ at least.
Japan customer guidance — Varun Jain, Dolat Capital
PartialLast year ₹72 Cr; expect same run-rate continue, so ₹80 Cr = ~10%. Japan very slow; many projects under discussion.
Solar business volatility — Varun Jain, Dolat Capital
AnsweredProject-based business; Q4 typically strong (depreciation benefit). FY27 revenue ₹200 Cr ~₹7-8% EBITDA margin.
Customer concentration — Varun Jain, Dolat Capital
AnsweredAll named are top customers. Top 10 customers ~80% of revenue spread across 80+ plants globally. High wallet share 80-90% with major customers.
Advantek margin expectations — Uttam Purohit, VVD Asset Mgmt
AnsweredQ1 ~9% (impacted by material costs). Will match India EBITDA margin next year. Currently in ramp phase.
China delay implications — Varun Jain, Dolat Capital
AnsweredChina will see low growth in FY28; benefit accelerates from FY29 onward.
Margin recovery path — Jason Soans, IDBI Capital
AnsweredYes, RM costs will reduce margin percentage despite absolute value increase; also capex ramp-up costs impact FY27.
PAT outgrowth thesis — Resham Jain, VBD Asset Mgmt
AnsweredYes, especially this year. Q-o-Q Advantek losses will reduce dramatically; if Romania turns around, even more leverage.
Guidance
FY27 India high-teens growth (upgraded from mid-teens)
HighQ1 delivered 21% YoY supports high-teens; driven by Bushing 30%, Stamping 30%, core Cages 10%+ growth
FY27 consolidated low-to-medium teens growth
Medium10-15% band; India high-teens + foreign low single-digit (China 10%, Romania <10%) blends to low-teens
Advantek ₹140 Cr+ revenue FY27 (vs ₹43 Cr FY26)
LowRequires 3.25x growth in 9 months; Q1 only ₹30 Cr; management confident but execution risk high
Bushing 30% growth FY27 (base ₹127 Cr FY26)
HighQ1 ₹34 Cr (+35% YoY); strong visibility on orders; conversion effects expected to continue 1-2 years
Stamping 30% growth FY27 (base ₹60 Cr FY26)
HighQ1 ₹90 Cr (inconsistent with base; likely includes new products); new product pipeline strong (AC, railways)
India margin 20-22% sustainable (vs 24% Q1 standalone)
MediumAssumes RM pass-through in Q2-Q3; also incorporates capex ramp costs; lag risk if pass-through delayed
Consolidated EBITDA 18% expected (vs 16% Q1)
MediumDepends on metal price stabilization; management noted if stable, margin reverts to prior 18.7%
China EBITDA 12-14% range; PAT ~6%
HighStable margins demonstrated; Brownfield expansion expected to maintain similar profile
FY27 CapEx ₹50-80 Cr (Q1 ₹37 Cr)
HighBhayla Phase-2 + China Phase-2 + regular maintenance; total ₹180-200 Cr over 2 years announced
Risks the call surfaced
Margin recovery timing
HighRM pass-through lag extends margin pressure into H2 FY27; customer price resistance or competitive dynamics may prevent full recovery; OPM down 150 bps YoY.
Advantek ramp-up execution
High₹140 Cr FY27 revenue target requires ~₹35 Cr/qtr burn-rate from current ₹30 Cr; PAT positive by FY27-end unproven; Phase-2 capex announced before Phase-1 fully ramped.
Romania profitability path
HighLosses continue despite topline growth; new management/strategy still in early stage; breakeven timeline pushed to 'maybe next year' (unverified); ₹2 Cr FX loss in Q1 masks operational issues.
Large-Cages ramp slowness
MediumQ1 only ₹10 Cr despite 50% FY27 growth target; new facility ramping slower than expected; high-value segment at risk if ramp delays persist.
Japan customer deceleration
MediumQ1 ₹21 Cr (+25% YoY) but FY27 guidance only 10% (₹80 Cr); slow project pipeline acknowledged; development conversion cycle lengthy unverified.
Management
Score 7/10. Transparent on headwinds (FX ₹4 Cr, RM ₹8 Cr, war ₹3 Cr); specific cost impacts quantified. Somewhat opaque on China/Romania separate financials (consolidated reporting). Credible on timing lag explanations. Hit prior double-digit revenue guidance; met/beat key product growth targets (Bushing 35%, Stamping 31%). Margin guidance walked down cautiously (24% → 20-22%), showing realism. Advantek and subsidiary recovery track record unproven.
1 · Q2 FY27 (Oct 2026)
RM cost pass-through impact visible; margin recovery signal
2 · H2 FY27
Advantek ramp accelerates toward ₹140 Cr annual run-rate target
3 · Q3 FY28
China brownfield expansion commissioned; FY29 full impact
Margin recovery hinges on RM pass-through timing and Advantek needing 3.25x growth in 9 months.
Harsha Q1 FY27: consol. PAT flat YoY, capex squeezes margin despite 25% revenue growth
PAT -1.4% YoY · revenue +25.2% · margins compressing · miss vs street
₹457.43 Cr
+25.2% YoY
₹37.38 Cr
-1.4% YoY
8.08%
-2pp YoY
₹4.11
Harsha Engineers International's consolidated Q1 FY27 (quarter ended June 30, 2026) revenue rose 25.2% YoY to ₹457.4 Cr (from ₹365.3 Cr), well ahead of management's double-digit FY27 topline guidance and above the ₹280-300 Cr standalone revenue band flagged in our pre-result preview (standalone revenue came in at ₹316.3 Cr). But profit did not scale with revenue: consolidated PAT was ₹37.4 Cr, down 1.4% YoY (₹37.9 Cr) and down 20.9% sequentially from ₹47.2 Cr in Q4 FY26, with EPS at ₹4.11 versus ₹4.17 a year ago — inside the preview's ₹3.8-4.2 range, but only because margin gave way. Net profit margin compressed to 8.1% of total income from 10.1% (YoY) and 9.8% (QoQ). Full-year FY27 street consensus (Simply Wall St, 3 analysts) pegs revenue near ₹1,870 Cr and EPS at ₹21.00; this quarter's ₹4.11 EPS is roughly 20% of that annual target, a plausible pace for a seasonally lighter Q1 but not conclusive on its own.
Q1 FY-2027 vs prior quarters
The compression is concentrated in the core Engineering & Others segment: its PBT margin fell to ~11.9% of segment revenue from ~15.0% a year ago and ~15.3% last quarter, with segment PBT (₹50.2 Cr) down 3.9% YoY and 14.3% QoQ even as segment revenue grew 20.7% YoY and 10.2% QoQ to ₹421.1 Cr — cost growth outpaced the topline in the business itself. That's compounded at the consolidated level by capex-linked financing costs: finance costs jumped 126.8% YoY to ₹5.83 Cr and depreciation rose 30.9% YoY to ₹13.78 Cr, consistent with the ₹110-crore China and Advantek-phase-2 build-out our preview flagged. This is the direct answer to that preview's "can margins hold through capex" question — no, they didn't: margin ended the quarter at ~11.9%, at or slightly below the 12-13% bear case the preview itself called out, and below management's own guidance of "at least maintaining the current margin profile." The revenue-growth leg of guidance was beaten; the margin leg was missed.
The stock went into the print at ₹419, down 0.8% over the past month of trading.
Management guides for overall double-digit topline growth in FY27, driven by a more aggressive mid-teens growth in the core India Engineering business. They are confident in at least maintaining the current margin profile, with an ambition to improve it by 100-200 basis points at the consolidated level over the next 2-
— This quarter: missed
The ₹457.4 Cr headline also masks a mix effect: Solar-EPC & O&M segment revenue, which is lumpy and project-timing driven, fell 60.4% sequentially to ₹36.4 Cr from ₹91.8 Cr in Q4 (still up 120.8% YoY from ₹16.5 Cr), accounting for most of the -3.5% QoQ consolidated revenue decline — the core Engineering business did not slow sequentially. This quarter's limited review was the first conducted by newly appointed statutory auditor Mukesh M. Shah & Co. (appointed July 23, 2026, replacing the predecessor auditor), a routine rotation rather than a governance flag. No standalone management press release or commentary was available in the filing to cross-check against these numbers. Standalone and consolidated tell a consistent story — standalone PAT ₹45.7 Cr on ₹316.3 Cr revenue, EPS ₹5.02 — with no material divergence in growth trend between the two bases.
W1
Engineering segment PBT margin fell to ~11.9% this quarter from ~15%; watch whether it recovers toward management's 'at least maintain' commitment as new capacity ramps to full utilization
W2
Finance costs (+126.8% YoY to ₹5.83 Cr) and depreciation (+30.9% YoY to ₹13.78 Cr) tied to the ₹110 Cr capex; watch whether incremental revenue from the new capacity outpaces this drag in coming quarters
W3
Solar-EPC & O&M segment revenue swung from ₹91.8 Cr (Q4) to ₹36.4 Cr (Q1) on project timing; watch next quarter's run-rate before reading QoQ consolidated-revenue swings as trend
Converted from ₹ Lakhs as reported. Consolidated PBT includes ₹0.03 Cr share of Cleanmax Harsha Solar JV profit; no exceptional items in either statement. Segment note shows core Engineering & Others PBT margin fell to ~11.9% (Q1FY27) from ~15.0-15.3% (Q1FY26/Q4FY26); Solar-EPC revenue is lumpy (₹36.4 Cr vs ₹91.8 Cr in Q4), explaining most of the QoQ consolidated revenue dip despite core Engineering growth.
₹457 Crore Revenue, ₹37 Crore Profit — The Margin Recovery Thesis Starts Here
Harsha delivered 25% revenue growth but flat profit, pivoting management guidance lower on raw material pass-through lag. The call reveals why the street sold off day-1, and what it will take to believe the margin rebound.
₹457.4 Cr
+25.2% YoY
₹37.4 Cr
-1.5% YoY
15.9%
−150 bps YoY
21% YoY
6% QoQ
The gap between this quarter's topline and bottom line is the entire story. Harsha's revenue engine is firing—25% consolidated growth, 21% in the core India engineering segment, and 35% in bushing. But net profit barely moved. On the call, management downgraded the year-ahead margin band from 24% (Q1 standalone) to 20–22%, citing 8% raw material cost inflation and a 1–2 quarter lag before customer price acceptance kicks in. The street's -2.08% day-1 sell-off was not overreaction; it was the market repricing the company from a "growth inflects profit" narrative to a "grow into margin compression" one.
Where the profit compression came from
EBITDA fell 150 basis points year-over-year—to 15.9% from 17.4%—despite 25% revenue growth. Two factors explain it. First, raw material prices (brass, copper, zinc, steel, polymer) rose 8% globally; the company operates on indexed pricing with a 1–2 quarter lag, so Q1 bore the cost inflation before customer passes-through became visible. Second, a ₹4 crore FX hedge loss on Romania operations masked an otherwise stronger operating result. Together, these created the arithmetic: revenue up 25%, EBITDA margin down 150 bps, and profit down 1.5%. Management is confident the RM pass-through will normalize margins by H2 FY27, but that depends on customer acceptance and competitive dynamics—neither guaranteed.
Satisfactory Q1 performance in line with management plan
OverstatedRevenue +25% YoY beat guidance; PAT −1.5% despite topline growth missed margin expectations
Pass-through of 8% RM increase will normalize margins in Q2
PartialOPM fell 150 bps YoY; pass-through timing unverified, depends on customer acceptance and competitive dynamics
Strong 21% growth in India Engineering with 6% QoQ growth
SupportedConfirmed; India segment delivered exactly 21% YoY and 6% QoQ despite macro headwinds
Bushing targeting 30% growth FY27 with strong visibility
SupportedQ1 delivered 35% YoY; order book and pipeline assurances backed by new product pipeline (wind, EV)
Advantek ₹140 Cr+ revenue target for FY27
ContradictedQ1 ₹30 Cr, FY26 ₹43 Cr; requires ₹35 Cr/qtr run-rate from current ₹30 Cr over 9 months—3.25x growth highly aggressive
What changed on this call
India growth guidance upgraded: mid-teens → high-teens (16%+ support)
Japan customer downgraded: 25% Q1 growth but guiding only 10% FY27 (₹80 Cr); slow project pipeline
Margin band narrowed: 24% Q1 standalone → 20–22% FY27 guidance (RM costs + capex ramp)
Romania losses timeline pushed: 'gradual reduction' to ₹2–3 Cr by FY27 end; breakeven now 'maybe next year'
The market's take
On day 1, the stock fell 2.08% with heavy delivery (84.5%), signaling institutional selling. By day 3, it recovered only +0.44%—a clear verdict that the market doesn't believe the RM pass-through thesis yet. At ₹412.25, the stock is 12.1% below its all-time high of ₹469, trading below its 50-day moving average (₹416.39) but above its 200-day (₹389.38). Volume has increased, but momentum remains neutral (RSI 53.3). FII ownership trimmed 0.58 percentage points in Q1 (now 1.79%), while domestic institutions added 0.59 percentage points (now 13.02%), suggesting foreign investors are skeptical of the margin recovery narrative while DIIs are buying the capex thesis. The street is right to wait: until Q2 shows RM pass-through visibly restoring EBITDA margin toward 18%+, the stock deserves to trade in the ₹390–₹420 range, not back toward the highs.
The bull-bear ledger
25% consolidated revenue growth; 21% India segment growth despite macro headwinds
Bushing +35% YoY; Stamping +31% YoY; new product pipeline (wind gearbox, rails, aerospace, EV) credible
India export ₹139 Cr (+22% YoY); broad-based global demand across Europe, US, bearing OEMs
CapEx execution on track: Bhayla Phase-2 construction rolling; China brownfield Q3 FY28 commissioning
PAT flat (−1.5%) despite 25% topline growth; margin compression unresolved, not a temporary cost spike
Margin guidance walked down: 24% → 20–22%; recovery depends on customer acceptance of price hikes (unproven)
Advantek needs 3.25x growth in 9 months to hit ₹140 Cr; PAT positive by FY27-end unverified
Romania continues loss-making despite topline growth; breakeven timeline pushed to 'maybe FY28'; combined China + Romania loss ₹6 Cr still
Japan customer guidance downgraded to 10% FY27 despite 25% Q1 growth; project pipeline described as 'very slow'
Large-size Cages only ₹10 Cr in Q1 vs 50% FY27 growth target; new facility ramping slower than expected
Risks, ranked by how much they should concern a holder
RM cost pass-through acceptance & timing
High8% material cost increase is pending 1–2 quarter lag. If customers resist price hikes or competitive dynamics prevent full pass-through, margin recovery extends beyond H2 FY27. OPM down 150 bps YoY is structural, not cyclical.
Advantek ramp-up execution
High₹140 Cr FY27 target requires ₹35 Cr/qtr run-rate starting Q2; Q1 was only ₹30 Cr. PAT positive by FY27-end is unproven. Any stumble in new customer wins or product adoption derails the target and compounds margin dilution.
Romania profitability path unclear
HighCombined China + Romania loss ₹6 Cr in FY26; guiding ₹2–3 Cr by FY27-end. Q1 saw ₹2 Cr FX loss on Romania, masking operational issues. Management hedged with 'gradually reduce losses' and 'maybe next year' breakeven—precision is absent.
Large-size Cages ramp slowness
MediumQ1 only ₹10 Cr vs 50% FY27 growth target (implying ₹50 Cr+ revenue). New facility underutilized; if ramp delays persist, the high-value segment becomes a drag on consolidated margin recovery.
Japan customer deceleration
MediumQ1 ₹21 Cr (+25% YoY) but FY27 guidance only 10% (₹80 Cr). Slow project pipeline acknowledged. If new projects don't materialize, the segment underperforms and reduces consolidated revenue visibility.
The debate
What to watch next
1 · Q2 FY27 EBITDA margin recovery (October 2026)
This is the linchpin. If India segment EBITDA margin rebounds to 22%+ in Q2, the RM pass-through narrative holds and margin recovery is underway. If it stays 19–20%, customers are resisting price hikes and the bear case (margin compression structural) has teeth. Watch consolidated EBITDA margin; if it's 17%+, the pass-through is working.
2 · Advantek sequential ramp (Q2 & Q3 FY27)
Q1 was ₹30 Cr; Q2 needs to be ₹32+ Cr and Q3 ₹35+ Cr to reach the ₹140 Cr FY27 target. If Advantek stalls at ₹30–31 Cr/qtr, the 3.25x growth target is at risk, and PAT positive by FY27-end becomes unlikely. EBITDA margin at Advantek (management guided 9% in Q1) is also critical; if it stays 8–10%, the subsidiary remains a dilutant.
3 · Romania + China loss trajectory (H2 FY27)
Management guided ₹2–3 Cr combined loss by FY27-end (vs ₹6 Cr in Q1). If H2 shows losses narrowing materially, the turnaround narrative gains credibility. If combined losses stay ₹5+ Cr, the subsidiary drag persists and the bull case weakens.
This is steady execution, not a step-change. Harsha is growing revenue and scaling capex on time, but margin recovery is uncertain and execution risk is real. The stock deserves to trade below the ₹430–₹469 range (near-term highs) until Q2 proves the RM pass-through is working. The single number to track from here is India segment EBITDA margin in Q2; if it's 22%+, the bull case re-rates and the stock moves back toward ₹420+. If it's 20% or lower, the market's skepticism is justified and the stock stays range-bound. Hold for the capex upside (FY28–29), but don't chase the near-term margin recovery story until it's visible.